Brain-on-a-chip
(BoC) concepts should consider three-dimensional
(3D) scaffolds to mimic the 3D nature of the human brain not accessible
by conventional planar cell culturing. Furthermore, the essential
key to adequately address drug development for human pathophysiological
diseases of the nervous system, such as Parkinson’s or Alzheimer’s,
is to employ human induced pluripotent stem cell (iPSC)-derived neurons
instead of neurons from animal models. To address both issues, we
present electrophysiologically mature human iPSC-derived neurons cultured
in BoC applicable microscaffolds prepared by direct laser writing.
3D nanoprinted tailor-made elevated cavities interconnected by freestanding
microchannels were used to create defined neuronal networksas
a proof of conceptwith two-dimensional topology. The neuronal
outgrowth in these nonplanar structures was investigated, among others,
in terms of neurite length, size of continuous networks, and branching
behavior using z-stacks prepared by confocal microscopy
and cross-sectional scanning electron microscopy images prepared by
focused ion beam milling. Functionality of the human iPSC-derived
neurons was demonstrated with patch clamp measurements in both current-
and voltage-clamp mode. Action potentials and spontaneous excitatory
postsynaptic currentsfundamental prerequisites for proper
network signalingprove full integrity of these artificial
neuronal networks. Considering the network formation occurring within
only a few days and the versatile nature of direct laser writing to
create even more complex scaffolds for 3D network topologies, we believe
that our study offers additional approaches in human disease research
to mimic the complex interconnectivity of the human brain in BoC studies.
We tested the growth of human iPSC-derived NPCs on nanowire arrays across a wide range of array characteristics. The proliferation, viability, and interaction with the nanowire arrays were mapped depending on the array pitch and nanowire length.
Nanostructured cell culture substrates featuring nanowire (NW) arrays have been applied to a variety of basic cell lines and rodent neurons to investigate cellular behavior or to stimulate cell responses. However, patient-derived human neurons—a prerequisite for studying e.g. neurodegenerative diseases efficiently—are rarely employed due to sensitive cell culture protocols and usually long culturing periods. Here, we present human patient induced pluripotent stem cell-derived neurons cultured on densely-spaced spiky silicon NW arrays (600 NWs/ 100 µm$$^2$$
2
with NW lengths of 1 µm) which show mature electrophysiological characteristics after only 20 days of culturing. Exemplary neuronal growth and network formation on the NW arrays are demonstrated using scanning electron microscopy and immunofluorescence microscopy. The cells and neurites rest in a fakir-like settling state on the NWs only in contact with the very NW tips shown by cross-sectional imaging of the cell/NW interface using focused ion beam milling and confocal laser scanning microscopy. Furthermore, the NW arrays promote the cell culture by slightly increasing the share of differentiated neurons determined by the quantification of immunofluorescence microscopy images. The electrophysiological functionality of the neurons is confirmed with patch-clamp recordings showing the excellent capability to fire action potentials. We believe that the short culturing time to obtain functional human neurons generated from patient-derived neural progenitor cells and the robustness of this differentiation protocol to produce these neurons on densely-spaced spiky nanowire arrays open up new pathways for stem cell characterization and neurodegenerative disease studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.